Cencora (COR) Income Statement

NYSE: CORRevenue, profits, margins and EPS over 10 years.

COR FY2025 at a glance

Fiscal year ended September 30, 2025 · U.S. dollars
Revenue+9.3%
$321.33B
FY2025 · hover or tap a bar for each year
FY2016: $146.85B (+8.0%)FY2017: $153.14B (+4.3%)FY2018: $167.94B (+9.7%)FY2019: $179.59B (+6.9%)FY2020: $189.89B (+5.7%)FY2021: $213.99B (+12.7%)FY2022: $238.59B (+11.5%)FY2023: $262.17B (+9.9%)FY2024: $293.96B (+12.1%)FY2025: $321.33B (+9.3%)
FY2016FY2025
Gross profit+16.6%
$10.14B
FY2025 · hover or tap a bar for each year
FY2016: $3.77B (+17.4%)FY2017: $4.15B (+9.9%)FY2018: $4.11B (−0.9%)FY2019: $4.53B (+10.2%)FY2020: $4.79B (+5.8%)FY2021: $6.27B (+30.8%)FY2022: $7.60B (+21.2%)FY2023: $7.76B (+2.1%)FY2024: $8.70B (+12.2%)FY2025: $10.14B (+16.6%)
FY2016FY2025
Operating income+20.0%
$3.65B
FY2025 · hover or tap a bar for each year
FY2016: $1.68B (+28.7%)FY2017: $2.02B (+19.9%)FY2018: $1.65B (−18.2%)FY2019: $1.87B (+13.1%)FY2020: $2.02B (+8.5%)FY2021: $2.68B (+32.1%)FY2022: $2.75B (+2.9%)FY2023: $2.45B (−11.1%)FY2024: $3.04B (+24.3%)FY2025: $3.65B (+20.0%)
FY2016FY2025
Net income+3.0%
$1.55B
FY2025 · hover or tap a bar for each year
FY2016: $1.43BFY2017: $414.5M (−71.0%)FY2018: $1.66B (+300.1%)FY2019: $855.4M (−48.4%)FY2020: −$3.40B (−497.4%)FY2021: $1.54BFY2022: $1.70B (+10.3%)FY2023: $1.75B (+2.7%)FY2024: $1.51B (−13.5%)FY2025: $1.55B (+3.0%)
FY2016FY2025
EPS (diluted)+16.2%
$15.99
FY2025 · hover or tap a bar for each year
FY2016: $5.62 (+13.3%)FY2017: $5.89 (+4.8%)FY2018: $6.48 (+10.0%)FY2019: $7.08 (+9.3%)FY2020: $7.90 (+11.6%)FY2021: $9.26 (+17.2%)FY2022: $11.02 (+19.0%)FY2023: $11.99 (+8.8%)FY2024: $13.76 (+14.8%)FY2025: $15.99 (+16.2%)
FY2016FY2025
Net profit margin−0.0 pts
0.5%
FY2025 · hover or tap a point for each year
FY2016: 1.0% (+1.1 pts)FY2017: 0.3% (−0.7 pts)FY2018: 1.0% (+0.7 pts)FY2019: 0.5% (−0.5 pts)FY2020: −1.8% (−2.3 pts)FY2021: 0.7% (+2.5 pts)FY2022: 0.7% (−0.0 pts)FY2023: 0.7% (−0.0 pts)FY2024: 0.5% (−0.2 pts)FY2025: 0.5% (−0.0 pts)
FY2016FY2025

COR revenue and net income

RevenueNet incomeNet margin (right axis)

Where COR's revenue goes

FY2025
Revenue
$321.33B100.0%
Cost of revenue
−$311.19B−96.8%
Gross profit
$10.14B3.2%
Sales, general & admin
−$6.49B−2.0%
Operating income
$3.65B1.1%
Interest & other expense
−$1.39B−0.4%
Income taxes
−$690.5M−0.2%
Net income
$1.55B0.5%

Each bar shows an amount and its share of revenue. COR kept 0.5% of revenue as net income.

COR profit margins

GrossOperatingNet

COR growth rates

to FY2025
1 year3 years5 years10 years
Revenue+9.3%+10.4%+11.1%+9.0%
Gross profit+16.6%+10.1%+16.2%+12.2%
Operating income+20.0%+9.9%+12.5%+10.8%
Net income+3.0%−2.9%——
EPS (diluted)+16.2%+13.2%+15.1%+12.4%

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

COR quarterly EPS vs estimates

Reported EPSAnalyst estimate

Cencora beat the analyst EPS estimate in 8 of the last 8 quarters. Next report: November 4, 2026 (estimate $4.54).

COR income statement

Cencora annual income statement
FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$321.33B$293.96B$262.17B$238.59B$213.99B$189.89B$179.59B$167.94B$153.14B$146.85B
Cost of revenue$311.19B$285.26B$254.42B$230.99B$207.72B$185.10B$175.06B$163.83B$149.00B$143.08B
Gross profit$10.14B$8.70B$7.76B$7.60B$6.27B$4.79B$4.53B$4.11B$4.15B$3.77B
Sales, general & admin$6.49B$5.66B$5.31B$4.85B$3.59B$104.3M$76.4M$67.8M$61.7M$58.0M
Total operating expenses$6.49B$5.66B$5.31B$4.85B$3.59B$2.77B$2.66B$2.46B$2.13B$2.09B
Operating income$3.65B$3.04B$2.45B$2.75B$2.68B$2.02B$1.87B$1.65B$2.02B$1.68B
Interest income$128.2M$91.7M$228.9M$21.3M$8.5M$20.6M$37.7M———
Interest expense$419.8M$248.7M$275.6M$232.0M$182.5M$158.5M$195.5M$189.6M$149.0M$144.3M
Income before taxes$2.26B$2.00B$2.16B$2.18B$2.22B−$5.29B$967.1M$1.18B$917.9M$1.39B
Income taxes$690.5M$484.7M$428.3M$516.5M$677.3M−$1.89B$113.0M−$438.5M$553.4M−$37.0M
Net income$1.55B$1.51B$1.75B$1.70B$1.54B−$3.40B$855.4M$1.66B$414.5M$1.43B
EBITDA$3.75B$3.37B$3.42B$3.12B$2.91B−$4.73B$1.65B$1.87B$1.49B$1.92B
EPS (diluted)$15.99$13.76$11.99$11.02$9.26$7.90$7.08$6.48$5.89$5.62
Gross margin3.2%3.0%3.0%3.2%2.9%2.5%2.5%2.4%2.7%2.6%
Operating margin1.1%1.0%0.9%1.2%1.3%1.1%1.0%1.0%1.3%1.1%
Net margin0.5%0.5%0.7%0.7%0.7%−1.8%0.5%1.0%0.3%1.0%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in COR's financial statements (latest annual report filed November 25, 2025); data from EODHD. Sales, general & administrative expenses include sales and marketing.

COR financial results

In fiscal year 2025 (ended September 30, 2025), Cencora reported revenue of $321.3 billion, up 9.3% from the year before. It had net income of $1.6 billion (up 3.0%), a net profit margin of 0.5%. Diluted earnings per share came to $15.99. Over five years revenue grew at an average rate of 11.1% a year.

See the COR stock overview for the latest quote and news, or the COR chart for price history and technical indicators.

COR income statement FAQ

What is Cencora's annual revenue?

Cencora reported total revenue of $321.3 billion for fiscal year 2025, which ended on September 30, 2025. That was up 9.3% from $294.0 billion the previous year.

Is Cencora profitable?

Yes. Cencora reported net income of $1.6 billion in fiscal 2025, a net profit margin of 0.5%; its operating margin was 1.1%.

What is Cencora's gross margin?

Cencora's gross margin was 3.2% in fiscal 2025: for every $100 of revenue, Cencora kept $3 after the direct cost of its products and services.

How fast is Cencora growing?

Revenue grew 11.1% a year on average over the last five fiscal years, from $189.9 billion to $321.3 billion.

What are Cencora's earnings per share?

Cencora earned $15.99 per diluted share in fiscal 2025, compared with $13.76 a year earlier.

When will Cencora report its next earnings?

Cencora is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 before the market opens.

When does Cencora's fiscal year end?

Cencora's fiscal year ends in September. The latest annual report covers the year ended September 30, 2025 and was filed on November 25, 2025.

Medical Distribution income statements